Protective Effect of Hydroxysafflor Yellow A on Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Rats

被引:0
|
作者
JIN Ming [1 ]
WANG Lin [1 ]
WU Yan [1 ]
ZANG Bao-xia [1 ]
TAN Li [1 ]
机构
[1] Department of Pharmacology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital,Capital Medical University
关键词
hydroxysafflor yellow A; pulmonary fibrosis; pulmonary inflammation; nuclear factor-κB p65; α-smooth muscle actin; Chinese medicine;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
摘要
Objective: To observe the effect of hydroxysafflor yellow A(HSYA), an active ingredient of a traditional Chinese herbal medicine Carthamus tinctorius L., on lung inflammation and pulmonary fibrosis induced by bleomycin(BLM) in rats. Methods: Animals were divided into 6 groups including normal group, model group, three HSYA groups and dexamethasone(DXM) group. Three doses of HSYA(35.6, 53.3, and 80.0 mg·kg;·day;) were intraperitoneally(i.p.) injected in rats for 3 weeks after BLM administration and DXM was used as the positive control(n=8 or 12). Arterial blood gas was assayed and morphological changes were observed. Lung mRNA expressions of tumor necrosis factor(TNF)-α, interleukin(IL)-1β, IL-6 and some cytokines in lung tissue were detected by real-time polymerase chain reaction. Nuclear factor-κB p65 or α-smooth muscle actin(α-SMA) protein distribution in rat lung tissue was observed by immunohistochemistry. Results: On the 7 th day after BLM administration, lung tissue showed serious inflammation. Treatment with HSYA or DXM ameliorated lung inflammation. After treatment with HSYA or DXM, oxygen partial pressure(PaO;) increased(HSYA 80.0 mg·kg;, P<0.01) and CO;partial pressure(PaCO;) decreased(HSYA 53.3, 80.0 mg·kg;, P<0.05). Moreover, the mRNA expression of TNF-α, IL-1β, and IL-6; and the number of NF-κB p65 positive cells was lower in HSYA 53.3 and 80.0 mg·kg;groups than those in the model group(all P<0.05). Twenty-one days after BLM administration, HSYA or DXM treatment ameliorated fibrosis, increased PaO;(HSYA 53.3, 80.0 mg·kg;, P<0.01), and decreased PaCO;(53.3 and 80.0 mg·kg;, P<0.05). Further, the mRNA expression of TGF-β1, α-SMA, and collagen Ⅰ as well as the number of α-SMA positive cells increased in the model group and HSYA can attenuate these changes(53.3, 80.0 mg·kg;, P<0.05). Hematoxylin and eosin and Masson’s trichrome staining indicated that the fibrosis and collagen deposition were ameliorated in HSYA groups(53.3, 80.0 mg·kg;, P<0.05). Conclusion: HSYA could alleviate acute lung inflammation and chronic pulmonary fibrosis induced by BLM in rats.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [31] ASTRAGALOSIDE ALLEVIATES BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN RATS
    Yu, Wei-Na
    Sun, Li-Feng
    Yang, Hua
    ACTA MEDICA MEDITERRANEA, 2017, 33 (06): : 1151 - 1156
  • [32] Protective and therapeutic effect of felodipine against bleomycin-induced pulmonary fibrosis in mice
    Ken-ichiro Tanaka
    Tomomi Niino
    Tomoaki Ishihara
    Ayaka Takafuji
    Takahiro Takayama
    Yuki Kanda
    Toshifumi Sugizaki
    Fumiya Tamura
    Shota Kurotsu
    Masahiro Kawahara
    Tohru Mizushima
    Scientific Reports, 7
  • [33] Protective roles of polysaccharides from Ganoderma lucidum on bleomycin-induced pulmonary fibrosis in rats
    Chen, Jianhui
    Shi, Yingying
    He, Lian
    Hao, Hairong
    Wang, Baolan
    Zheng, Yulong
    Hu, Chengping
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2016, 92 : 278 - 281
  • [34] Zingerone Attenuates bleomycin-Induced Pulmonary Fibrosis in Rats
    Mansouri, Mohammad Taghi
    Vardanjani, Hossein Rajabi
    Hemmati, Ali Asghar
    Tabandeh, Mohammad Reza
    Rezaie, Anahita
    Pashmforosh, Marzie
    Angali, Kambiz Ahmadi
    JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS, 2019, 14 (01)
  • [35] Curcumin inhibition of bleomycin-induced pulmonary fibrosis in rats
    Punithavathi, D
    Venkatesan, N
    Babu, M
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (02) : 169 - 172
  • [36] Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats
    Wang, HD
    Yamaya, M
    Okinaga, S
    Jia, YX
    Kamanaka, M
    Takahashi, H
    Guo, LY
    Ohrui, T
    Sasaki, H
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (03) : 406 - 411
  • [37] Feitai attenuates bleomycin-induced pulmonary fibrosis in rats
    Gong, LK
    Li, XH
    Wang, H
    Zhang, L
    Cai, Y
    Qi, XM
    Liu, LL
    Liu, YZ
    Wu, XF
    Chen, FP
    Huang, CG
    Ren, J
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (05) : 634 - 640
  • [38] Protective role of uteroglobin against bleomycin-induced pulmonary fibrosis
    Lee, YC
    Zhang, ZJ
    Hitomi, E
    Mukherjee, A
    FASEB JOURNAL, 2005, 19 (04): : A279 - A279
  • [39] Protective Role of Andrographolide in Bleomycin-Induced Pulmonary Fibrosis in Mice
    Zhu, Tao
    Zhang, Wei
    Xiao, Min
    Chen, Hongying
    Jin, Hong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (12): : 23581 - 23596
  • [40] The Integrin Inhibitor Cilengitide and Bleomycin-Induced Pulmonary Fibrosis Cilengitide and Bleomycin-Induced Pulmonary Fibrosis
    Ritzenthaler, Jeffrey D.
    Zhang, Michael
    Torres-Gonzalez, Edilson
    Roman, Jesse
    LUNG, 2020, 198 (06) : 947 - 955